Literature DB >> 19838641

Hypertension in Ireland: public awareness and doctors choice of therapy.

N L Zaharan1, A Mahmud, K Bennett, J Feely.   

Abstract

BACKGROUND: Hypertension is the commonest medical condition in Ireland. AIMS: (1) To examine the level of awareness of blood pressure (BP) in the population and (2) to ascertain the opinion of general practitioners (GPs) in diagnosis and management of hypertension.
METHODS: BP measurements and assessment of BP awareness were performed in a sub-sample of the general population (n = 1,071). The opinion of GPs (n = 1,037) on hypertension was determined in a postal survey.
RESULTS: Amongst the population sampled (45 ± 13 years, mean age ± SD), almost half had elevated BP (>140/90 mmHg) but only half of those were already on antihypertensives. 40% had no knowledge of their BP and 54% were not aware of what constituted normal BP. While some 80% of GPs said they followed British guidelines, their practice was more in keeping with the European guidelines. Approximately, 90% of GPs required ambulatory BP recording to confirm diagnosis of hypertension. First choice antihypertensive agents were ACE inhibitors and angiotensin receptor antagonists in younger patients and diuretics and ACE inhibitors in older patients.
CONCLUSION: These results suggest that there is a need for further public education on BP and nationally agreed hypertension guidelines.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19838641     DOI: 10.1007/s11845-009-0367-8

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  27 in total

Review 1.  Stroke is more common than myocardial infarction in hypertension: analysis based on 11 major randomized intervention trials.

Authors:  S E Kjeldsen; S Julius; T Hedner; L Hansson
Journal:  Blood Press       Date:  2001       Impact factor: 2.835

2.  Primary care prescribing patterns in Ireland after the publication of large hypertension trials.

Authors:  Zubair Kabir; John Feely; Kathleen Bennett
Journal:  Br J Clin Pharmacol       Date:  2007-07-04       Impact factor: 4.335

3.  The value of ambulatory blood pressure in older adults: the Dublin outcome study.

Authors:  Marian L Burr; Eamon Dolan; Eoin W O'Brien; Eoin T O'Brien; Patricia McCormack
Journal:  Age Ageing       Date:  2008-03       Impact factor: 10.668

4.  Determinants of new-onset diabetes among 19,257 hypertensive patients randomized in the Anglo-Scandinavian Cardiac Outcomes Trial--Blood Pressure Lowering Arm and the relative influence of antihypertensive medication.

Authors:  Ajay K Gupta; Bjorn Dahlof; Joanna Dobson; Peter S Sever; Hans Wedel; N R Poulter
Journal:  Diabetes Care       Date:  2008-01-30       Impact factor: 19.112

5.  Global burden of hypertension: analysis of worldwide data.

Authors:  Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul Muntner; Paul K Whelton; Jiang He
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

6.  Cardiovascular disease prevention: the new Joint British Societies' guidelines.

Authors:  Michael F Laker
Journal:  Ann Clin Biochem       Date:  2006-09       Impact factor: 2.057

7.  Control of blood pressure in Scotland: the rule of halves.

Authors:  W C Smith; A J Lee; I K Crombie; H Tunstall-Pedoe
Journal:  BMJ       Date:  1990-04-14

Review 8.  Medication nonadherence: an unrecognized cardiovascular risk factor.

Authors:  Mark A Munger; Benjamin W Van Tassell; Joanne LaFleur
Journal:  MedGenMed       Date:  2007-09-19

9.  Hypertension treatment and control in five European countries, Canada, and the United States.

Authors:  Katharina Wolf-Maier; Richard S Cooper; Holly Kramer; José R Banegas; Simona Giampaoli; Michel R Joffres; Neil Poulter; Paola Primatesta; Birgitta Stegmayr; Michael Thamm
Journal:  Hypertension       Date:  2003-11-24       Impact factor: 10.190

Review 10.  The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review.

Authors:  J A Cramer; A Benedict; N Muszbek; A Keskinaslan; Z M Khan
Journal:  Int J Clin Pract       Date:  2007-11-05       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.